287 related articles for article (PubMed ID: 33667384)
1. MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism.
Ueda K; Kumari R; Schwenger E; Wheat JC; Bohorquez O; Narayanagari SR; Taylor SJ; Carvajal LA; Pradhan K; Bartholdy B; Todorova TI; Goto H; Sun D; Chen J; Shan J; Song Y; Montagna C; Xiong S; Lozano G; Pellagatti A; Boultwood J; Verma A; Steidl U
Cancer Cell; 2021 Apr; 39(4):529-547.e7. PubMed ID: 33667384
[TBL] [Abstract][Full Text] [Related]
2. MDMX inhibits casein kinase 1α activity and stimulates Wnt signaling.
Huang Q; Chen L; Schonbrunn E; Chen J
EMBO J; 2020 Jul; 39(14):e104410. PubMed ID: 32511789
[TBL] [Abstract][Full Text] [Related]
3. Murine double minute X plays a central role in leukemic transformation and may be a promising target for leukemia prevention strategies.
Ueda K
Exp Hematol; 2023 Jun; 122():10-18. PubMed ID: 37086813
[TBL] [Abstract][Full Text] [Related]
4. Cellular carcinogenesis in preleukemic conditions:drivers and defenses.
Ueda K; Ikeda K
Fukushima J Med Sci; 2024 Jan; 70(1):11-24. PubMed ID: 37952978
[TBL] [Abstract][Full Text] [Related]
5. Regeneration-associated WNT signaling is activated in long-term reconstituting AC133bright acute myeloid leukemia cells.
Beghini A; Corlazzoli F; Del Giacco L; Re M; Lazzaroni F; Brioschi M; Valentini G; Ferrazzi F; Ghilardi A; Righi M; Turrini M; Mignardi M; Cesana C; Bronte V; Nilsson M; Morra E; Cairoli R
Neoplasia; 2012 Dec; 14(12):1236-48. PubMed ID: 23308055
[TBL] [Abstract][Full Text] [Related]
6. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
[No Abstract] [Full Text] [Related]
7. LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells.
Morgan RG; Ridsdale J; Payne M; Heesom KJ; Wilson MC; Davidson A; Greenhough A; Davies S; Williams AC; Blair A; Waterman ML; Tonks A; Darley RL
Haematologica; 2019 Jul; 104(7):1365-1377. PubMed ID: 30630973
[TBL] [Abstract][Full Text] [Related]
8. CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt/β-catenin signaling pathway.
Ji H; Chen L; Xing Y; Li S; Dai J; Zhao P; Wang Y
Pediatr Res; 2019 Jun; 85(7):1024-1031. PubMed ID: 30862962
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived CK1α mutations enhance MDMX inhibition of p53.
Liu X; Huang Q; Chen L; Zhang H; Schonbrunn E; Chen J
Oncogene; 2020 Jan; 39(1):176-186. PubMed ID: 31462704
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miR92a Promotes Cytarabine Resistance in Myelodysplastic Syndromes by Activating Wnt/β-catenin Signal Pathway.
Li H; Xie C; Lu Y; Chang K; Guan F; Li X
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291656
[TBL] [Abstract][Full Text] [Related]
11. β-Catenin Is a Candidate Therapeutic Target for Myeloid Neoplasms with del(5q).
Li L; Sheng Y; Li W; Hu C; Mittal N; Tohyama K; Seba A; Zhao YY; Ozer H; Zhu T; Qian Z
Cancer Res; 2017 Aug; 77(15):4116-4126. PubMed ID: 28611040
[TBL] [Abstract][Full Text] [Related]
12. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.
Ma Y; Cui W; Yang J; Qu J; Di C; Amin HM; Lai R; Ritz J; Krause DS; Chai L
Blood; 2006 Oct; 108(8):2726-35. PubMed ID: 16763212
[TBL] [Abstract][Full Text] [Related]
13. SOSTDC1 acts as a tumor inhibitor in acute myeloid leukemia by downregulating the Wnt/β-catenin pathway.
Li C; Wang M; Shi Y; Xin H
Environ Toxicol; 2022 Aug; 37(8):1934-1943. PubMed ID: 35442555
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia.
Zhai H; Zhao J; Pu J; Zhao P; Wei J
Turk J Haematol; 2021 Dec; 38(4):264-272. PubMed ID: 34431643
[TBL] [Abstract][Full Text] [Related]
15. [TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in human acute myeloid leukemia].
Sakoda T; Kikushige Y
Rinsho Ketsueki; 2023; 64(6):547-552. PubMed ID: 37407480
[TBL] [Abstract][Full Text] [Related]
16. DIXDC1 promotes the growth of acute myeloid leukemia cells by upregulating the Wnt/β-catenin signaling pathway.
Xin H; Li C; Wang M
Biomed Pharmacother; 2018 Nov; 107():1548-1555. PubMed ID: 30257373
[TBL] [Abstract][Full Text] [Related]
17. Propofol inhibits biological functions of leukaemia stem and differentiated cells through suppressing Wnt/β-catenin and Akt/mTOR.
Chen L; Wan Y; Liu Y; Li T
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):127-134. PubMed ID: 31429973
[TBL] [Abstract][Full Text] [Related]
18. Increased FLYWCH1 Expression is Negatively Correlated with Wnt/β-catenin Target Gene Expression in Acute Myeloid Leukemia Cells.
Almars A; Chondrou PS; Onyido EK; Almozyan S; Seedhouse C; Babaei-Jadidi R; Nateri AS
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167387
[TBL] [Abstract][Full Text] [Related]
19. Amide-linked local anesthetics preferentially target leukemia stem cell through inhibition of Wnt/β-catenin.
Ni J; Xie T; Xiao M; Xiang W; Wang L
Biochem Biophys Res Commun; 2018 Sep; 503(2):956-962. PubMed ID: 29932919
[TBL] [Abstract][Full Text] [Related]
20. DACT3 has a tumor-inhibiting role in acute myeloid leukemia via the suppression of Wnt/β-catenin signaling by DVL2.
Gao Q; Hou L; Wang H; Xun L
J Biochem Mol Toxicol; 2022 May; 36(5):e23014. PubMed ID: 35187752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
